180 related articles for article (PubMed ID: 28936272)
41. Cancer care inequity for women in resource-poor countries.
Varughese J; Richman S
Rev Obstet Gynecol; 2010; 3(3):122-32. PubMed ID: 21364864
[TBL] [Abstract][Full Text] [Related]
42. A model-based assessment of the cost-utility of strategies to identify Lynch syndrome in early-onset colorectal cancer patients.
Snowsill T; Huxley N; Hoyle M; Jones-Hughes T; Coelho H; Cooper C; Frayling I; Hyde C
BMC Cancer; 2015 Apr; 15():313. PubMed ID: 25910169
[TBL] [Abstract][Full Text] [Related]
43. Gynaecological neoplasms in common familial syndromes (Lynch and HBOC).
Bartosch C; Clarke B; Bosse T
Pathology; 2018 Feb; 50(2):222-237. PubMed ID: 29287922
[TBL] [Abstract][Full Text] [Related]
44. Gaining insight into the supportive care needs of women experiencing gynaecological cancer: A qualitative study.
Williams N; Griffin G; Farrell V; Hauck YL
J Clin Nurs; 2020 May; 29(9-10):1684-1694. PubMed ID: 32065476
[TBL] [Abstract][Full Text] [Related]
45. Genetic counseling and cascade genetic testing in Lynch syndrome.
Hampel H
Fam Cancer; 2016 Jul; 15(3):423-7. PubMed ID: 26969309
[TBL] [Abstract][Full Text] [Related]
46. Hereditary cancer syndromes with high risk of endometrial and ovarian cancer: surgical options for personalized care.
McCann GA; Eisenhauer EL
J Surg Oncol; 2015 Jan; 111(1):118-24. PubMed ID: 25139656
[TBL] [Abstract][Full Text] [Related]
47. [Counselling, genetic testing and prevention in women with hereditary breast- and ovarian cancer. Interdisciplinary recommendations of the consortium "Hereditary Breast- and Ovarian Cancer" of the German Cancer AiD].
Schmutzler R; Schlegelberger B; Meindl A; Gerber WD; Kiechle M;
Zentralbl Gynakol; 2003 Dec; 125(12):494-506. PubMed ID: 14755360
[TBL] [Abstract][Full Text] [Related]
48. A new paradigm of genetic testing for hereditary breast/ovarian cancers.
Kwong A; Chen JW; Shin VY
Hong Kong Med J; 2016 Apr; 22(2):171-7. PubMed ID: 26980575
[TBL] [Abstract][Full Text] [Related]
49. Feasibility of genetic testing for cancer risk assessment programme in Nigeria.
Adejumo PO; Aniagwu TIG; Awolude OA; Oni AO; Ajayi OO; Fagbenle O; Ogungbade D; Kochheiser M; Ogundiran T; Olopade OI
Ecancermedicalscience; 2021; 15():1283. PubMed ID: 34824606
[TBL] [Abstract][Full Text] [Related]
50. [Tuberculosis in Asia].
Kekkaku; 2002 Oct; 77(10):693-7. PubMed ID: 12440145
[TBL] [Abstract][Full Text] [Related]
51. Attention to bone health in follow-up of gynaecological cancers in tertiary care.
O'Gorman CA; Minnock S; Mulhall J; Gleeson N
Womens Health (Lond); 2022; 18():17455065211070747. PubMed ID: 34994250
[TBL] [Abstract][Full Text] [Related]
52. Prophylactic Gynecologic Specimens from Hereditary Cancer Carriers.
Shaw PA; Clarke BA
Surg Pathol Clin; 2016 Jun; 9(2):307-28. PubMed ID: 27241111
[TBL] [Abstract][Full Text] [Related]
53. Multi-disciplinary summit on genetics services for women with gynecologic cancers: A Society of Gynecologic Oncology White Paper.
Randall LM; Pothuri B; Swisher EM; Diaz JP; Buchanan A; Witkop CT; Bethan Powell C; Smith EB; Robson ME; Boyd J; Coleman RL; Lu K
Gynecol Oncol; 2017 Aug; 146(2):217-224. PubMed ID: 28596016
[TBL] [Abstract][Full Text] [Related]
54. Association of benign gynaecological diseases and risk of endometrial and ovarian cancers.
Shen F; Liu Y; Lin L; Zhao M; Chen Q
J Cancer; 2020; 11(11):3186-3191. PubMed ID: 32231723
[No Abstract] [Full Text] [Related]
55. Contraceptive retail surveys locate problems of acceptance.
Netw Res Triangle Park N C; 1985; 6(4):6-7. PubMed ID: 12340326
[TBL] [Abstract][Full Text] [Related]
56. Chien-Tien Hsu Memorial Lecture. Fertility and gynaecologic malignancies.
Sivanesaratnam V
J Obstet Gynaecol Res; 2001 Feb; 27(1):1-15. PubMed ID: 11330724
[TBL] [Abstract][Full Text] [Related]
57. Exploring clinicians' attitudes about using aspirin for risk reduction in people with Lynch Syndrome with no personal diagnosis of colorectal cancer.
Chen Y; Peate M; Kaur R; Meiser B; Wong T; Kirk J; Ward RL; Goodwin A; Macrae F; Hiller J; Trainer AH; Mitchell G
Fam Cancer; 2017 Jan; 16(1):99-109. PubMed ID: 27677266
[TBL] [Abstract][Full Text] [Related]
58. Hereditary Cancer Syndromes and Risk Assessment: ACOG COMMITTEE OPINION SUMMARY, Number 793.
Obstet Gynecol; 2019 Dec; 134(6):1366-1367. PubMed ID: 31764755
[TBL] [Abstract][Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
